SCHEMBL3505581

SCHEMBL3505581

Oc1ccc2c(NCCN3CCOCC3)noc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 2/20 0.50
▸ HSP90AB1 P08238 1/20 0.50
▸ LMNA P02545 4/20 0.45
▸ HIF1A Q16665 2/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ PTK2B Q14289 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ TOP2A P11388 1/20 0.45
▸ CYP3A4 P08684 5/20 0.44
▸ CYP1A2 P05177 4/20 0.44
▸ CYP2D6 P10635 4/20 0.44
▸ HSD17B10 Q99714 3/20 0.44
▸ CLK4 Q9HAZ1 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ CHRM1 P11229 1/20 0.43
▸ CNR1 P21554 1/20 0.43
▸ ACHE P22303 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3504380 0.93 ALDH1A1 (0.48) HSP90AA1HSP90AB1LMNAMEN1KMT2A
SCHEMBL6953674 0.90 HSP90AA1 (0.55) HSP90AA1HSP90AB1LMNAHIF1AMEN1
SCHEMBL3504603 0.87 ESR1 (0.38) HSP90AA1HSP90AB1CYP3A4HSD17B10ALDH1A1
SCHEMBL3505061 0.85 KDM4E (0.53) HSP90AA1HSP90AB1LMNAMEN1KMT2A
SCHEMBL3510105 0.83 ALDH1A1 (0.50) HSP90AA1HSP90AB1LMNAMEN1KMT2A
SCHEMBL6959886 0.82 ALDH1A1 (0.53) LMNAHIF1AMEN1KMT2ANPSR1
SCHEMBL3505036 0.82 ALDH1A1 (0.58) LMNAHIF1AMEN1KMT2APOLB
SCHEMBL9085767 0.80 NR1I3 (0.46) HSP90AA1HSP90AB1POLBCYP3A4CYP1A2
SCHEMBL8184622 0.79 CYP3A4 (0.45) HSP90AA1HSP90AB1LMNAHIF1AMAPT
SCHEMBL3504318 0.79 ACHE (0.41) HSP90AA1HSP90AB1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5494908-A ANTIDEPRESSANT HOECHST-ROUSSEL PHARMACEUTICAL INCORPORATED (US) 1996-02-27 — — US claimed
US-20100247543-A1 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES ORYZON GENOMICS, S.A. (ES) 2010-09-30 — — US disclosed
EP-0669920-B1 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS AVENTIS PHARMA INC (US) 2003-02-12 — — EP disclosed
US-6046203-A USEFUL FOR THE TREATMENT OF VARIOUS MEMORY DYSFUNCTIONS CHARACTERIZED BY A DECREASED CHOLINERGIC FUNCTION SUCH AS ALZHEIMER'S DISEASE; ALSO INHIBIT MONOAMINE OXIDASE AND HENCE ARE USEFUL AS ANTIDEPRESSANTS AVENTIS PHARMACEUTICALS INC. (US) 2000-04-04 — — US disclosed
US-5925766-A COGNITION ACTIVATORS FOR DECREASING CHOLINERGIC FUNCTION OF ALZHEIMER*S DISEASE AND ARE ENZYME INHIBITORS OF MONOAMINE OXIDASE AND ARE ANTIDEPRESSANTS HOECHST MARION ROUSSEL, INC. (US) 1999-07-20 — — US disclosed
US-5756754-A Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds HOECHST MARION ROUSSEL, INC. (US) 1998-05-26 — — US disclosed
US-5580982-A ANTIDEPRESSANTS; ANTICHOLINERGIC AGENTS; ALZHEIMER'S DISEASE; AMINE OXIDASE INHIBITORS HOECHST MARION ROUSSEL INC. (US) 1996-12-03 — — US disclosed
US-5494908-A ANTIDEPRESSANT HOECHST-ROUSSEL PHARMACEUTICAL INCORPORATED (US) 1996-02-27 — — US disclosed
EP-0669920-A4 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS. HOECHST ROUSSEL PHARMA (US) 1995-10-25 — — EP disclosed
EP-0669920-A1 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS HOECHST MARION ROUSSEL, Inc. (US) 1995-09-06 — — EP disclosed
WO-1994012495-A1 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1994-06-09 — — WO disclosed
Send feedback